Screening of maternal serum for fetal Down's syndrome in the first trimester

New England Journal of Medicine

Volumn 338, Issue 14, 1998, Pages 955-961

  Haddow, James E ^a,c   Palomaki, Glenn E ^a   Knight, George J ^a   Williams, Josephine ^a   Miller, Wayne A ^b   Johnson, Anthony ^b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b Prenatal Diagnostic Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FLUOROIMMUNOASSAY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0032473926     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199804023381404     Document Type: Article

References (41)

1. Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, Donhowe JM. Maternal serum screening for Down syndrome in the United States: a 1995 survey. Am J Obstet Gynecol 1997;176:1046-51.
2. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum α-fetoprotein (AFP) and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-94.
3. Haddow JE, Kloza EM, Smith DE, Knight GJ. Data from an alphafetoprotein pilot screening program in Maine, Obstet Gynecol 1983;62: 556-60.
4. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fctoprotein measurement: a screening test for Down syndrome. Lancet 1984;1: 926-9.
5. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30.
6. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ, Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaccol 1988;95:330-3.
7. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7 [Erratum, BMJ 1988;297:1029.]
8. Brambati B, Simuni G, Bonacchi I, Piceni L. Fetal chromosomal aneuploidies and maternal serum alpha-fetoprotein levels in first trimester Lancet 1986;2:165-6.
9. Cuckle HS, Wald NJ, Barkai G, et al. First-trimester biochemical screening for Down syndrome. Lancet 1988;2:851-2.
10. Wald NJ, Kennard A, Hackshaw AK, First trimester serum screening for Down's syndrome. Prenat Diagn 1995;15:1227-40. [Erratum, Prenat Diagn 1996;16:387]
11. Ozturk M, Milunsky A, Brambati B, Sachs ES, Miller SL, Wands JR. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18. Am J Med Genet 1990;36:480-3.
12. Wald N, Stone R, Cuckle HS, et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ 1992;305:28.
13. Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996;103:407-12.
14. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
15. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-9.
16. Szabo J, Gellen J, Szemere G. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995;5:161-3.
17. Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996;7:216-26.
18. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 1996;16:1115-9.
19. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotcin level. Br J Obstet Gynaecol 1987;94:387-402.
20. Macintosh MC, Wald NJ, Chard T, et al. Correction: the selective miscarriage of Down's syndrome from 10 weeks of pregnancy. Br J Obstet Gynaccol 1994,102:798-801.
21. Cuckle H, Lilford RJ, Tcisner B, Holding S, Chard T, Grudzinskas JG. Pregnancy associated plasma protein A in Down's syndrome. BMJ 1992; 305:425.
22. Knight GJ, Palomaki GE, Haddow JE, Miller W, Bersinger NA, Schneider H. Pregnancy associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy. Prenat Diagn 1993;13: 222-3.
23. Scott F, Boogert A, Sinosich M, Anderson J. Establishment and application of a normal range for nuchal translucency across the first trimester Prenat Diagn 1996;16:629-34.
24. Cuckle HS, Wald NJ, Barkai G, et al. First-trimester biochemical screening for Down syndrome. Lancet 1988;2:851-2.
25. Bogart MH, Golbus MS, Sorg ND, Jones OW. Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses. Prenat Diagn 1989;9:379-84.
26. Brock DJ, Barron L, Holloway S, Liston WA, Millier SG, Seppala M. First-trimester maternal scrum biochemical indicators in Down syndrome. Prenat Diagn 1990;10:245-51.
27. Johnson A, Cowchock FS, Darby M, Wapner R, Jackson LG. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies. Prenat Diagn 1991;11:443-50.
28. Kratzer PG, Golbus MS, Monroe SE, Finkelstein DE, Taylor RN, Firsttrimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone. Prenat Diagn 1991;11:751-63.
29. Hogdall CK, Hogdall EV, Arends J, Norgaard-Pcdersen B, Smidt-Tensen S, Larsen SO. CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters. Prenat Diagn 1992;12:223-7
30. Van Lith JMM. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders, Prenat Diagn 1992;12:495-504.
31. Iles RK, Sharma K, Wathen NC, et al. hCG, free subunit and PAPP-A composition of maternal serum in normal and Down's syndrome pregnancies. Presented at the Fourth Conference on Endocrinology and Metabolism in Human Reproduction, London, May 24-26, 1993. abstract.
32. Aitken DA, McCaw G, Crossley JA, et al. First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat Diagn 1993;13:681-9.
33. Crandall BF, Hanson FW, Keener S, Matsumoto M, Miller W. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities. Am J Obstet Gynecol 1993;168: 1864-9.
34. Macintosh MC, Iles R, Teisner B, et al. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A., markers for fetal Down syndrome at 8-14 weeks. Prenat Diagn 1994;14: 203-8.
35. Brizot ML, Snijders RJ, Butler J, Bersinger NA, Nicolaides KH. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynaecol 1995;102:127-32.
36. Forest JC, Masse J, Rousseau F, Moutquin JM, Brideau NA, Belanger M. Screening for Down syndrome during the first and second trimesters: impact of risk estimation parameters. Clin Biochem 1995;28:443-9.
37. Jauniaux E, Nicolaides KH, Nagy A-M, Brizot M, Meuris S. Total amount of circulating human chorionic gonadotropin α and β subunits in first trimester trisomies 21 and 18. J Endocrinol 1996;148:27-31.
38. Aitken DA, Wallace EM, Crossley JA, et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996;334: 1231-6.
39. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet 1992;99:144-9.
40. Konyne LM, Smith JC, Ramick M, Lawson HW. Abortion surveillance - United States, 1989. MMWR Morb Mortal Wkly Rep 1993;41(SS-5): 1-33.
41. Wald NJ, Hackshaw A, Stone R, Densem J. Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. Prenat Diagn 1993;13:1047-50.